Showing results (1-10 of 172) with videos related to
Sort By:
Pageof 18
Expert Review of Clinical Pharmacology|May 31, 2014
Kidney function assessment and its role in drug development, review and utilizationMichael A Tortorici, Thomas D NolinJournal of Clinical Pharmacology|December 16, 2014
Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney diseaseMichael A Tortorici, David L Cutler, Anasuya Hazra, et al.Current Opinion in Nephrology and Hypertension|October 23, 2008
Altered nonrenal drug clearance in ESRDThomas D NolinSeminars in Dialysis|April 10, 2015
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKDThomas D NolinThe Journal of Pharmacology and Experimental Therapeutics|August 11, 2019
Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of <sup>14</sup>CO<sub>2</sub> Production Rate DataYoko Franchetti, Thomas D NolinJournal of Clinical Pharmacology|January 18, 2021
Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance PathwaysYoko Franchetti, Thomas D NolinHandbook of Experimental Pharmacology|December 19, 2009
Mechanisms of drug-induced nephrotoxicityThomas D Nolin, Jonathan HimmelfarbJournal of Clinical Pharmacology|November 18, 2020
Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and SimulationYoko Franchetti, Thomas D NolinExpert Review of Clinical Pharmacology|September 15, 2017
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney diseaseAlexander J Prokopienko, Thomas D NolinCurrent Drug Metabolism|June 6, 2016
Implications of Kidney Disease on Metabolic ReductionOsama Y Alshogran, Thomas D NolinPageof 18